These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21420486)

  • 21. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
    Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.
    Zang YC; Skinner SM; Robinson RR; Li S; Rivera VM; Hutton GJ; Zhang JZ
    Mult Scler; 2004 Oct; 10(5):499-506. PubMed ID: 15471364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells.
    Nagai T; Devergne O; van Seventer GA; van Seventer JM
    Scand J Immunol; 2007 Feb; 65(2):107-17. PubMed ID: 17257215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-β treatment requires B cells for efficacy in neuroautoimmunity.
    Schubert RD; Hu Y; Kumar G; Szeto S; Abraham P; Winderl J; Guthridge JM; Pardo G; Dunn J; Steinman L; Axtell RC
    J Immunol; 2015 Mar; 194(5):2110-6. PubMed ID: 25646307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    J Neuroimmunol; 2001 Dec; 121(1-2):102-10. PubMed ID: 11730946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis.
    Kress-Bennett JM; Ehrlich GD; Bruno A; Post JC; Hu FZ; Scott TF
    BMC Neurol; 2011 Dec; 11():155. PubMed ID: 22182694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression.
    Remoli ME; Gafa V; Giacomini E; Severa M; Lande R; Coccia EM
    Eur J Immunol; 2007 Dec; 37(12):3499-508. PubMed ID: 17985330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production.
    Huang YM; Adikari S; Båve U; Sanna A; Alm G
    J Neuroimmunol; 2005 Jan; 158(1-2):204-12. PubMed ID: 15589055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; Ciric B; Touil T; Harle H; Grammatikopolou J; Das Sarma J; Gran B; Zhang GX; Rostami A
    J Immunol; 2007 Sep; 179(5):3268-75. PubMed ID: 17709543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.
    Balashov KE; Aung LL; Vaknin-Dembinsky A; Dhib-Jalbut S; Weiner HL
    Ann Neurol; 2010 Dec; 68(6):899-906. PubMed ID: 21061396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis.
    Wang X; Chen M; Wandinger KP; Williams G; Dhib-Jalbut S
    J Immunol; 2000 Jul; 165(1):548-57. PubMed ID: 10861095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase.
    Koda T; Namba A; Kinoshita M; Nakatsuji Y; Sugimoto T; Sakakibara K; Tada S; Shimizu M; Yamashita K; Takata K; Ishikura T; Murata S; Beppu S; Kumanogoh A; Mochizuki H; Okuno T
    J Neuroinflammation; 2020 Mar; 17(1):82. PubMed ID: 32169103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.